These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13174000)

  • 21. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intravenous lipid tolerance test in patients with liver cirrhosis].
    Lugli R; Baldelli MV; Salati R; Salvioli GF
    Minerva Gastroenterol; 1975; 21(4):212-6. PubMed ID: 1228492
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of glucagon test in liver cirrhosis].
    Kurochka Iu; Shpaniar E; Levchik A; Zagradni V; Golan I
    Klin Med (Mosk); 1977 Nov; 55(11):73-6. PubMed ID: 606995
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on pyruvate tolerance test in liver cirrhosis.
    el-Hawary MF; Ragab AM; Sakr R; el-Zawahry K
    J Egypt Med Assoc; 1969 Apr; 52(4):229-44. PubMed ID: 5397616
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical significance of simultaneous Weltmann test and Brdicka's filtration reaction].
    SUDA M; SACHLOVA M
    Cas Lek Cesk; 1954 Jun; 93(26):721-3. PubMed ID: 13182685
    [No Abstract]   [Full Text] [Related]  

  • 26. [The ammonia tolerance test in intra- and extrahepatic portal vein block].
    Ziegler K
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):229-32. PubMed ID: 5732402
    [No Abstract]   [Full Text] [Related]  

  • 27. [Correlation between liver biopsy and liver function tests in the diagnosis of liver cirrhosis].
    Ohta Y; Ohkubo H; Hatori K; Shinomiya M
    Rinsho Byori; 1986 Jun; 34 Spec No 67():154-61. PubMed ID: 3773278
    [No Abstract]   [Full Text] [Related]  

  • 28. [Scintigraphic and serlogic liver examinations--comparison of results].
    Bessler W; Jucker A
    Schweiz Med Wochenschr; 1967 Sep; 97(35):1146-51. PubMed ID: 5593647
    [No Abstract]   [Full Text] [Related]  

  • 29. Laboratory tests for diagnosis of autoimmune diseases.
    Nakamura RM; Chisari FV; Edgington TS
    Prog Clin Pathol; 1975; 6():177-203. PubMed ID: 1105671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tolerance of galactose and bromsulfthalein in liver cirrhosis. A comment to a reply].
    Järnerot G
    Nord Med; 1971 Mar; 85(11):351-2. PubMed ID: 5553213
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteoporosis in liver cirrhosis--overview.
    Cijevschi C; Mihai C; Drug VL; Zbranca E; Gogălniceanu P
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):700-4. PubMed ID: 16610162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal glucose tolerance: a predictor of 30-day mortality in patients with decompensated liver cirrhosis.
    Hagel S; Bruns T; Herrmann A; Stallmach A; Schmidt C
    Z Gastroenterol; 2011 Mar; 49(3):331-4. PubMed ID: 21391163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of liver cirrhosis developing from chronic viral hepatitis--liver function tests].
    Okabe K
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1575-80. PubMed ID: 1774521
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of liver function tests in diagnosis of chronic hepatitis and liver cirrhosis].
    KONCHALOVSKAIA NM; PRISS IS
    Ter Arkh; 1958 Feb; 30(2):31-7. PubMed ID: 13569308
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of 1 -fetoprotein in the diagnosis of primary liver cell carcinoma].
    Müller GM; Geserick G
    Z Gesamte Inn Med; 1972 Dec; 27(24):1084-7. PubMed ID: 4347507
    [No Abstract]   [Full Text] [Related]  

  • 38. Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.
    Marmo R; Romano M; de Sio I; Peduto A; Caporaso N; Persico M; Coltorti M
    Ital J Gastroenterol; 1993 Jan; 25(1):1-8. PubMed ID: 8428017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Liver cirrhosis. Clinical and biological aspects].
    Hofstetter JR; Ebiner JR
    Schweiz Med Wochenschr; 1979 Jun; 109(25):934-7. PubMed ID: 37599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic validity of the intravenous galactose tolerance test in liver cirrhosis (author's transl)].
    Böhmer R; Rommel K
    Acta Hepatogastroenterol (Stuttg); 1972; 19(5):344-56. PubMed ID: 4668529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.